167992-87-2

Upstream product

• 17768-41-1 adamantylmethylamine 
• 154742-09-3 1(S)-<<<3,5-bis(benzyloxycarbonyl)phenyl>amino>carbonyl>-2-phenylethylamine 
• 338450-78-5 1-methylindole-5,6-dicarboxylic acid anhydride 
• 153602-71-2 dimethyl indole-5,6-dicarboxylate 
• 88330-42-1 dimethyl 1-methylindole-5,6-dicarboxylate 
• 88330-43-2 1-methylindole-5,6-dicarboxylic acid 
• 167992-88-3 5-[(S)-2-({6-[(Adamantan-1-ylmethyl)-carbamoyl]-1H-indole-5-carbonyl}-amino)-3-phenyl-propionylamino]-isophthalic acid dibenzyl ester 
• 74-88-4 methyl iodide 

Relevant academic research and scientific papers

Nonpeptide cholecystokinin-2 receptor agonists

In the course of structural explorations around a series of potent CCK2 receptor antagonists, it was noted that simple N-methylation of the indolic N-H in the parent molecule gave rise to behavior in vivo that was consistent with the compound acting as an agonist. Exploration in vitro confirmed this property, and it was shown that the agonist action could be blocked by the reference CCK2 receptor antagonist, L-365,260. Further examples of this type of modification were explored, and a common theme with regard to agonist behavior was uncovered. Some molecular modeling is also presented in an attempt to throw light on the nature of the ligand receptor interactions that may be giving rise to the differing properties of these, apparently, structurally similar molecules.